Towards the preclinical study of magnetic fluid hyperthermia: strategies for determining specific loss power and murine melanoma cell count
Magnetic fluid hyperthermia (MFH) is a potential cancer treatment which uses heat from the relaxation of magnetic nanoparticles (MNPs) under an applied alternating magnetic field to damage and kill cancer cells. To plan in vitro MFH treatments, the specific loss power (SLP) of the MNPs must be determined to quantify he...